Viemed Healthcare, Inc.

VMD Healthcare Medical Devices

Viemed Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $270.3 million, up 20.5% from fiscal 2024.

Revenue
+12.2%
EPS
+33.3%
Free cash flow
−67.6%
Total debt
−76.2%

Quarter to September 2026, against a year earlier

9.15 0.14 +1.55%
Market cap
$343.2M
P/E
22.0×
Fwd P/E
23.4×
Dividend yield
—
F-score
5/9
Altman Z
5.58
Beneish M
−3.18
Dividend safety
n/a

Viemed Healthcare, Inc. (VMD) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Viemed Healthcare, Inc. (VMD) trades at a P/E ratio of 22.0×. Over the past ten years it has ranged from 8.0× (January 2018) to 1,111,111× (April 2017); the current reading is higher than 29% of that period. That is below the Medical Devices industry median of 25.6× and below the Healthcare sector median of 25.2×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 19.1× (31.11%)
FY2024 27.7× (6.55%)
FY2023 29.6× (41.21%)
FY2022 50.3× 121.77%
FY2021 22.7× 136.90%
FY2020 9.6× (63.66%)
FY2019 26.4× 85.98%
FY2018 14.2× 76.16%
FY2017 8.0× (100.00%)
FY2016 1,104,377× —

Quarterly newest first

Period P/E ratio Change
Sep 2026 22.2× (26.02%)
Jun 2026 30.0× 27.04%
Mar 2026 23.6× 23.96%
Dec 2025 19.1× (1.80%)
31 more quarters

Against its own ten years

Low 8.0× High 1,111,111×
Ten-year median 27.0×
Current reading's percentile 29

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on VMD